Global Hereditary Cancer Testing Market
Healthcare Services

Hereditary Cancer Testing Market Forecast 2023: Forecast Market Size, Drivers And Key Segments

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global hereditary cancer testing market is poised for substantial growth, with expectations to elevate from $3.55 billion in 2022 to $3.95 billion in 2023, reflecting an impressive compound annual growth rate (CAGR) of 11.3%. As we gaze into the future, the market is anticipated to expand further, reaching $5.82 billion in 2027 at a steady CAGR of 10.2%.

Genetic Underpinnings: Driving Market Expansion

  • Prevalence of Hereditary Cancer:
    • The surge in hereditary cancer cases, fueled by mutations in specific genes passed from parents to children, propels the demand for hereditary cancer testing.
    • Hereditary cancer testing is instrumental in detecting disease-related gene mutations, enabling comprehensive cancer risk assessments.
  • Pancreatic Cancer and Genetic Background:
    • A significant revelation is found in the realm of pancreatic cancer, where approximately 10% of cases have a genetic background, as reported in a BioMed Central article.
    • The European software company SOPHiA Genetics emphasizes that hereditary factors contribute to about 10% of all cancer cases, with an estimated 20% of cancer patients having a family history of cancer.

Market Pioneers: Leaders Steering the Course

Major players in the hereditary cancer testing market play a crucial role in shaping its trajectory. Recognizable names include Centogene NV, Myriad Genetics Inc., Quest Diagnostics, and Illumina Inc., each contributing significantly to the market’s growth.

Technological Frontiers: Innovations Redefining Testing Landscape

  • Personalized Breast Cancer Risk Assessment:
    • Technological innovation emerges as a key trend, with key market players focusing on advancements to solidify their market positions.
    • Myriad Genetics, in March 2022, launched genetic testing with a Polygenic Breast Cancer Risk Assessment Score, offering personalized risk assessments for breast cancer to all women, irrespective of their ancestry.

Segmentation Insights: Navigating the Market Landscape

The global hereditary cancer testing market is intricately segmented, offering a nuanced understanding of its various facets:

  1. By Test Type:
    • Multi Panel Test
    • Single-site Genetic Test
  2. By Indication:
    • Breast Cancer
    • Ovarian Cancer
    • Colorectal Cancer
    • Other Indications
  3. By End User:
    • Hospital
    • Clinics
    • Diagnostic Centers

Regional Dynamics: North America at the Forefront

In 2022, North America emerged as the largest region in the hereditary cancer testing market, demonstrating the region’s pivotal role in shaping market trends. As the market unfolds, North America continues to lead, contributing significantly to the overall growth.

View More On The Hereditary Cancer Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report

Request A Sample Of The Global Hereditary Cancer Testing Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=8121&type=smp

The Hereditary Cancer Testing Global Market Report 2023  provides a comprehensive overview on the hereditary cancer testing market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the hereditary cancer testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Healthcare Analytical Testing Services Global Market Report 2023
Analytical Standards Global Market Report 2023
Testing, Inspection, And Certification Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/ 
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model